← FDA Drug Approvals (Drugs@FDA)

OXCARBAZEPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PAI HOLDINGS · Approved 2021-07-09

Drug application

FDA Application #

ANDA211420

Application type

Abbreviated New Drug Application (Generic)

Brand name

OXCARBAZEPINE

Generic name

Oxcarbazepine

Active ingredients

OXCARBAZEPINE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Discontinued

Sponsor

PAI HOLDINGS

First approval

2021-07-09

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown